These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1953813)

  • 1. The relative toxicity of nonsteroidal antiinflammatory drugs.
    Fries JF; Williams CA; Bloch DA
    Arthritis Rheum; 1991 Nov; 34(11):1353-60. PubMed ID: 1953813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reevaluation of aspirin therapy in rheumatoid arthritis.
    Fries JF; Ramey DR; Singh G; Morfeld D; Bloch DA; Raynauld JP
    Arch Intern Med; 1993 Nov; 153(21):2465-71. PubMed ID: 8215751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative toxicity of disease-modifying antirheumatic drugs.
    Fries JF; Williams CA; Ramey D; Bloch DA
    Arthritis Rheum; 1993 Mar; 36(3):297-306. PubMed ID: 8452574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward an understanding of NSAID-related adverse events: the contribution of longitudinal data.
    Fries J
    Scand J Rheumatol Suppl; 1996; 102():3-8. PubMed ID: 8628980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System.
    Singh G
    Am J Ther; 2000 Mar; 7(2):115-21. PubMed ID: 11319579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis.
    Fries JF; Murtagh KN; Bennett M; Zatarain E; Lingala B; Bruce B
    Arthritis Rheum; 2004 Aug; 50(8):2433-40. PubMed ID: 15334455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARAMIS and toxicity measurement. (Arthritis Rheumatism and Aging Medical Information System).
    Fries JF
    J Rheumatol; 1995 May; 22(5):995-7. PubMed ID: 8587097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.
    Singh G; Ramey DR; Morfeld D; Shi H; Hatoum HT; Fries JF
    Arch Intern Med; 1996 Jul; 156(14):1530-6. PubMed ID: 8687261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative toxicity of alternative therapies for rheumatoid arthritis: implications for the therapeutic progression.
    Fries JF; Williams CA; Ramey DR; Bloch DA
    Semin Arthritis Rheum; 1993 Oct; 23(2 Suppl 1):68-73. PubMed ID: 8278821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAID induced gastrointestinal complications: the ARAMIS perspective--1997. Arthritis, Rheumatism, and Aging Medical Information System.
    Singh G; Rosen Ramey D
    J Rheumatol Suppl; 1998 May; 51():8-16. PubMed ID: 9596549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative toxicity of non-steroidal anti-inflammatory agents.
    Singh G; Ramey DR; Morfeld D; Fries JF
    Pharmacol Ther; 1994; 62(1-2):175-91. PubMed ID: 7991642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
    Colebatch AN; Marks JL; Edwards CJ
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008872. PubMed ID: 22071858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use.
    Fries JF; Miller SR; Spitz PW; Williams CA; Hubert HB; Bloch DA
    Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):647-55. PubMed ID: 2909442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of nonsteroidal antiinflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic review.
    Colebatch AN; Marks JL; van der Heijde DM; Edwards CJ
    J Rheumatol Suppl; 2012 Sep; 90():62-73. PubMed ID: 22942332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Duration of use of non-steroidal anti-inflammatory agents in patients with rheumatoid arthritis].
    Luggen ME
    Rev Rhum Ed Fr; 1994 Dec; 61(10 Pt 2):165S-172S. PubMed ID: 7858568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
    Larkai EN; Smith JL; Lidsky MD; Graham DY
    Am J Gastroenterol; 1987 Nov; 82(11):1153-8. PubMed ID: 3499815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing and understanding patient risk.
    Fries JF
    Scand J Rheumatol Suppl; 1992; 92():21-4. PubMed ID: 1574684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy.
    Singh G
    Am J Med; 1998 Jul; 105(1B):31S-38S. PubMed ID: 9715832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsteroidal antiinflammatory drugs in rheumatoid arthritis: duration of use as a measure of relative value.
    Luggen ME; Gartside PS; Hess EV
    J Rheumatol; 1989 Dec; 16(12):1565-9. PubMed ID: 2625688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.